Turning Point Therapeutics Inc (TPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TPTX | CNTA | AMRX | ||
| Company | Turning Point Therapeutics Inc | Centessa Pharmaceuticals Plc ADR | Amneal Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 75.99 | 26.49 | 12.05 | ||
| High | 76.01 | 28.41 | 12.23 | ||
| Low | 75.98 | 26.33 | 11.93 | ||
| Latest | 76.01 | 28.29 | 11.94 | ||
| Change | +0.52 | +1.96 | +0.11 | ||
| % Change | +0.69% | +7.44% | +0.93% | ||
| Volume | 2,843,300 | 1,165,100 | 1,976,800 | ||
| 20-Day Average Volume | 962,475 | 1,189,555 | 2,211,580 | ||
| Previous Close | 75.49 | 26.33 | 11.83 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 75.11 | 26.37 | 13.66 | ||
| 20-Day Raw Stochastic | 100.00% | 89.35% | 5.18% | ||
| 20-Day Relative Strength | 74.20 | 61.01 | 31.16 | ||
| Weighted Alpha | -18.70 | +59.53 | +37.29 | ||
| Today's Opinion | 96% Buy | 88% Buy | 24% Buy | ||
| Previous Opinion | 96% Buy | 88% Buy | 40% Buy | ||
| Last Month's Opinion | 88% Buy | 40% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.29% since 08/09/22 | +8.43% since 03/09/26 | -9.89% since 03/09/26 | ||
| Low | 74.86 on 08/10/22 | 25.72 on 03/13/26 | 11.75 on 03/13/26 | ||
| High | 76.01 on 08/16/22 | 28.80 on 03/11/26 | 13.60 on 03/10/26 | ||
| 1-Month | |||||
| %Chg | +1.82% since 07/15/22 | +14.49% since 02/13/26 | -19.43% since 02/13/26 | ||
| Low | 74.57 on 07/21/22 | 24.01 on 02/20/26 | 11.75 on 03/13/26 | ||
| High | 76.01 on 08/16/22 | 28.80 on 03/11/26 | 15.42 on 02/17/26 | ||
| 3-Month | |||||
| %Chg | +134.02% since 05/16/22 | +9.99% since 12/16/25 | -1.89% since 12/16/25 | ||
| Low | 30.85 on 05/25/22 | 21.50 on 01/20/26 | 11.75 on 03/13/26 | ||
| High | 76.01 on 08/16/22 | 28.80 on 03/11/26 | 15.42 on 02/17/26 | ||
| 6-Month | |||||
| %Chg | +124.48% since 02/16/22 | +32.63% since 09/16/25 | +22.59% since 09/16/25 | ||
| Low | 23.77 on 03/15/22 | 17.05 on 11/05/25 | 9.49 on 09/25/25 | ||
| High | 76.01 on 08/16/22 | 30.58 on 12/08/25 | 15.42 on 02/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,806,125 | 3,845,470 | 3,718,915 | ||
| Shares Outstanding, K | 50,074 | 146,049 | 314,363 | ||
| Annual Sales | 30,830,000 | 0 | 3,018,760,000 | ||
| Annual Net Income | -236,550,000 | -235,760,000 | 72,060,000 | ||
| Last Quarter Sales | 120,000 | 0 | 814,320,000 | ||
| Last Quarter Net Income | -123,090,000 | -50,340,000 | 35,080,000 | ||
| 60-Month Beta | -0.18 | 1.55 | 1.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 08/08/22 | -0.41 on 11/05/25 | 0.17 on 10/30/25 | ||
| Latest Earnings Date | 11/08/22 | 03/23/26 | 05/01/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 15.57 | ||